Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
B12 doses ranging from 500-1000 mcg, with methionine, inositol, and choline ratios adjusted per formula
We provide: Expert guidance from healthcare providers Customized dosing plans tailored to your needs Ongoing education and support Convenient access to high-quality formulations* With Options Medical, your health and energy are supported every step of the way
It tracks closely with the metabolic deterioration that characterizes the third and fourth decades of life: rising fasting insulin, expanding visceral adipose tissue, declining mitochondrial density in skeletal muscle, and blunted exercise adaptability
The Substances on the Table These are the drugs being reviewed and the medical uses FDA will be evaluating: July 23, 2026: BPC-157 (free base and acetate) ulcerative colitis KPV (free base and acetate) wound healing and inflammatory conditions TB-500 (free base and acetate) wound healing MOTs-C (free base and acetate) obesity and osteoporosis July 24, 2026: Emideltide / DSIP (delta sleep-inducing peptide, free base and acetate) opioid withdrawal, chronic insomnia, and narcolepsy Semax (free base and acetate) cerebral ischemia, migraine, and trigeminal neuralgia Epitalon (free base and acetate) insomnia If any or all of these substances are added to the 503A Bulks List following this process, it would formalize the legal pathway for licensed pharmacists and physicians to compound them for patients
US$ 22.62
US$ 24.34
US$ 22.90